Bioequivalence testing to become compulsory for all ingredients of combined preparations, KFDA says

Published: 2010-07-22 06:56:00
Updated: 2010-07-22 06:56:00
From October 27, generic combination drugs to be produced in Korea must prove they are equivalent to the patented medicines on which they are modeled.

Those applicants who intend to seek approval of the generic combination products containing three ingredients should conduct bioequivalence tes...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.